Article

Cognitive impairment is now widely accepted as a fundamental aspect of
Parkinson's disease (PD). Given the prevalence of cognitive impairment and the
associated impact on well-being, evidence-based interventions are needed.
However, while research is continually accumulating in order to better understand
the pathology and trajectory of cognitive changes, treatment options lag behind.
Nonpharmacological approaches are of particular interest in this group, given the
typical polypharmacy already present in PD patients. In this regard, cognitive
training (CT) is a relatively new and prominent therapeutic option with
accumulating scientific support and increasing public awareness. Research has now
established benefits across many different populations, and trials investigating
the use of CT specifically in PD are becoming more common. We offer a brief
summary of CT and its efficacy in PD samples to date, as well as discuss areas
requiring further exploration in this group. Crucially, we suggest that CT should
be supported as a research priority in PD, given both proven and potential
benefits as a noninvasive and well-tolerated behavioral intervention for
cognitive impairment.

Langue : ANGLAIS